NUVL
Nuvalent, Inc. · Healthcare · Biotechnology
Señales de momentum (gestores comparables):
amplitud de titulares +10.0% ·
flujo de acciones +30.0% ·
nuevas posiciones netas +9.1%
— fórmula
Acumulación amplia — aumento de acciones entre más titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q3 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 97 | +1 | 28.33M | $3.50B | +17 | −15 |
| Q1 2026 | 98 | +7 | 37.97M | $3.87B | +12 | −6 |
| Q4 2025 | 90 | +2 | 41.80M | $4.20B | +4 | −1 |
| Q3 2025 | 16 | -2 | 30.34M | $2.62B | +1 | −4 |
| Q2 2025 | 16 | -1 | 25.82M | $1.97B | — | −1 |
| Q1 2025 | 14 | +1 | 6.74M | $477.77M | +1 | — |
| Q4 2024 | 13 | +1 | 7.00M | $548.03M | +1 | — |
| Q3 2024 | 11 | +1 | 4.59M | $469.19M | +1 | — |
| Q2 2024 | 10 | — | 3.29M | $249.85M | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 1.08M | +43.5% | $110.72M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 1.08M | +43.5% | $110.72M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | Wellington Management ✦ | 1.01M | +65.5% | $103.51M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | Wellington Management ✦ | 1.01M | +65.5% | $103.51M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | Wellington Management ✦ | 1.01M | +65.5% | $103.51M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | Wellington Management ✦ | 1.01M | +65.5% | $103.51M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | Wellington Management ✦ | 1.01M | +65.5% | $103.51M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | Wellington Management ✦ | 1.01M | +65.5% | $103.51M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | Wellington Management ✦ | 1.01M | +65.5% | $103.51M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | Wellington Management ✦ | 1.01M | +65.5% | $103.51M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | Geode Capital Management ✦ (pasivo) | 855.61K | +9.4% | $87.55M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | Geode Capital Management ✦ (pasivo) | 855.61K | +9.4% | $87.55M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | Adage Capital Partners ✦ | 280.00K | Nuevo | $28.64M | 0.1% | New | 1 | SEC ↗ |
| 14 | Norges Bank ✦ (pasivo) | 274.64K | -17.4% | $28.10M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | Two Sigma Investments ✦ | 262.39K | -7.2% | $26.84M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 16 | D. E. Shaw & Co. ✦ | 245.58K | -38.5% | $25.12M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | D. E. Shaw & Co. ✦ | 245.58K | -38.5% | $25.12M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 18 | Citadel Advisors ✦ | 242.56K | +4093.6% | $24.81M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 19 | Citadel Advisors ✦ | 242.56K | +4093.6% | $24.81M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 20 | Millennium Management ✦ | 180.35K | +546.7% | $18.45M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 21 | Marshall Wace ✦ | 141.70K | +68.5% | $14.50M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 9.25K | -30.8% | $946,070 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 9.25K | -30.8% | $946,070 | 0.0% | ▼ Trim | 2 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Adage Capital Partners | $28.64M | 0.1% |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 262 tenedores, 78.13M acciones, $7.62B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.